Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis

PURPOSE: The purpose of this study was to evaluate the efficacy and safety of induction chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) plus bevacizumab (BEV) on initially unresectable locally advanced gastric cancer (LAGC) or paraaortic lymph node (PAN) metastatic gastric cancer (GC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Kim, Beom Su, Yoo, Moon-Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Jihun, Byeon, Sun-Ju, Kang, Yoon-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912143/
https://www.ncbi.nlm.nih.gov/pubmed/28546521
http://dx.doi.org/10.4143/crt.2017.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912143/
https://www.ncbi.nlm.nih.gov/pubmed/28546521
http://dx.doi.org/10.4143/crt.2017.005

Ejemplares similares